Site Search
Search Results
Oregon Cancer Policy Luncheon to Address Cost of Breast Cancer in The State
... breast cancer. Research shows that access to quality and affordable health care coverage is key in the ability to fight cancer. Cancer is one of the leading causes of disease and death in the United States. An analysis by the American Cancer Society Cancer Action Network (ACS CAN) shows that cancer patients pay nearly $4 billion in out-of-pocket costs each year and the disease cost the country nearly $88 billion every year in health care spending. On Friday, October 26, a group of patient advocates, health care experts, ...
New Report Underscores Importance of RI Proposals Aiming to Limit Out-of-pocket Costs across Cancer Continuum
As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in ... MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them. While screening mammograms are free to most insured women starting at age 40, follow-up testing often ...
President Biden Urges Capping Medicare Patient Out-of-Pocket Drug Costs as Part of Prescription Pricing Policies
Washington, D.C— Today the president called on Congress to bring down patient prescription drug costs, an issue of critical importance to cancer patients. Among the provisions the president outlined was establishing an annual cap on Medicare enrollees’ ... out-of-pocket expenses. The following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN): “We greatly appreciate the president’s commitment to addressing prescription drug costs for patients, especially for those enrolled in Medicare. Cancer is a disease more common with age and can be very expensive to treat. For Medicare enrollees who currently face unlimited cost-sharing for some of their prescription drugs, the financial burden can be overwhelming. Establishing an annual cap for outpatient prescription ...
House Leadership Proposes Broad Legislation to Reduce Patient Out-Of-Pocket Drug Costs
... (D-Calif.), introduced legislation intended to bring down patient drug costs. The bill includes a provision to cap Medicare beneficiaries’ out-of-pocket prescription drug costs in Medicare Part D, allow the Health and Human Services (HHS) Secretary to negotiate prices for some drugs, and link select drug prices to the rates paid by other industrialized countries, among several other proposed changes. ACS CAN will continue to evaluate proposed provisions in the package to determine potential impact on cancer patients and survivors. A statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) follows: “We welcome Speaker Pelosi and House leadership’s action to address the ...
How Much Does Cancer Cost? New Report Examines Expected Patient Costs for Common Cancer Diagnoses
Washington, D.C.—The American Cancer Society Cancer Action Network (ACS CAN) today released its first report examining the costs of treating cancer, and specifically the out-of-pocket portion patients face. The report ... organization’s annual national policy forum, found U.S. cancer patients paid nearly $4 billion in out-of-pocket costs in 2014 and the disease cost the country $87.8 billion in cancer-related health care spending. The report examines costs for three of the most common cancers—breast, ...
New Report Underscores Importance of PA Proposal Limiting Out-of-pocket Costs for Diagnostic Tests for Breast Cancer
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. ... MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them. While screening mammograms are free to most insured women starting at age 40, follow-up testing after a ...
New Report Underscores Importance of VA Proposal Limiting Out-of-pocket Costs for Diagnostic Tests for Breast Cancer
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. ... MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them. While screening mammograms are free to most insured women starting at age 40, follow-up testing after a ...
Kansas Governor’s Veto of Short-Term Health Plans Bill Protects Patients from Extreme Costs
Topeka, Kan. – Today, Kansas Governor Laura Kelly vetoed Senate Bill 29, which would have exposed more Kansans to inadequate health plans that can avoid patient protections required by federal law. The American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, and Leukemia & Lymphoma Society oppose increasing the availability of Short Term Limited Duration Plans (STLDPs) because these plans often deny coverage to individuals with pre-existing conditions (which now include nearly 10% of Kansans who have had COVID-19), choose to not cover services related to those pre-existing conditions or charge enrollees higher premiums ...
New Report: Cancer Survivors Face High Costs of Care and Debt Years After Treatment
WASHINGTON, D.C.—December 8, 2022 —The costs of being diagnosed with cancer last long after the diagnosis and initial treatment putting cancer survivors at increased risk for lifelong financial hardship, according to a new report from the American Cancer Society Cancer Action Network (ACS CAN). The report, The Costs of Cancer Survivorship , examines several of the long-term expenses cancer survivors face in the years after they ... products offered to patients to pay their medical bills are not predatory. Capping all out-of-pocket costs in Medicare. Addressing unexpected cost-sharing for cancer screenings. Requiring coverage for cancer-related fertility preservation services. “While we’ve made significant ...
The Critical Role of Preventive Services without Cost Sharing for Cancer Prevention and Survivorship
... screening services alone have averted approximately 4.75 million deaths from breast, cervical, colorectal, lung and prostate cancers. Millions of people risk losing access to preventive services if cost sharing is required. Thanks to current protections in law, a vast majority of Americans have access to preventive services without cost ... negatively impact access to cancer prevention and screening, especially for the millions of people with limited incomes, for whom these payments can represent a significant percentage of their income. The Critical Role of Preventive Services without Cost Sharing for Cancer Prevention and ...
Type
- Action (3) Apply Action filter
- Basic page (111) Apply Basic page filter
- Blog Post (85) Apply Blog Post filter
- Event (1) Apply Event filter
- Landing Page (1) Apply Landing Page filter
- Press Release (1180) Apply Press Release filter
- Resource (52) Apply Resource filter
- State Priority (108) Apply State Priority filter
- Update (665) Apply Update filter
Priority Issue
State
- National (242) Apply National filter
- Maine (124) Apply Maine filter
- Massachusetts (120) Apply Massachusetts filter
- New York (119) Apply New York filter
- Vermont (117) Apply Vermont filter
- New Jersey (61) Apply New Jersey filter
- Pennsylvania (51) Apply Pennsylvania filter
- Connecticut (50) Apply Connecticut filter
- Ohio (45) Apply Ohio filter
- California (44) Apply California filter
- Maryland (34) Apply Maryland filter
- North Carolina (31) Apply North Carolina filter
- Florida (30) Apply Florida filter
- Michigan (27) Apply Michigan filter
- Tennessee (26) Apply Tennessee filter
- Kentucky (25) Apply Kentucky filter
- West Virginia (25) Apply West Virginia filter
- New Mexico (24) Apply New Mexico filter
- Illinois (23) Apply Illinois filter
- South Carolina (23) Apply South Carolina filter
- Texas (23) Apply Texas filter
- Wyoming (23) Apply Wyoming filter
- Oklahoma (21) Apply Oklahoma filter
- Colorado (20) Apply Colorado filter
- Missouri (20) Apply Missouri filter
- South Dakota (20) Apply South Dakota filter
- Arizona (19) Apply Arizona filter
- Georgia (19) Apply Georgia filter
- Indiana (19) Apply Indiana filter
- Arkansas (18) Apply Arkansas filter
- Nevada (18) Apply Nevada filter
- Oregon (18) Apply Oregon filter
- New Hampshire (16) Apply New Hampshire filter
- Rhode Island (16) Apply Rhode Island filter
- Alabama (15) Apply Alabama filter
- Montana (15) Apply Montana filter
- Idaho (14) Apply Idaho filter
- Louisiana (13) Apply Louisiana filter
- Minnesota (13) Apply Minnesota filter
- North Dakota (13) Apply North Dakota filter
- Virginia (13) Apply Virginia filter
- Alaska (12) Apply Alaska filter
- Mississippi (11) Apply Mississippi filter
- Nebraska (11) Apply Nebraska filter
- Utah (11) Apply Utah filter
- Kansas (10) Apply Kansas filter
- Washington (10) Apply Washington filter
- Delaware (9) Apply Delaware filter
- District Of Columbia (9) Apply District Of Columbia filter
- Hawaii (9) Apply Hawaii filter
Policy Issue
- Access to Health Care (16) Apply Access to Health Care filter
- Prevention and Early Detection (10) Apply Prevention and Early Detection filter
- Research, Funding and Drug Development (3) Apply Research, Funding and Drug Development filter
- Health Equity (2) Apply Health Equity filter
- Patient Quality of Life (2) Apply Patient Quality of Life filter